Relapses
A total of 25 patients relapsed, constituting 17.4%. The relapse rate is higher among stage III (17) patients and stage IV (6) patients. One patient had progressive disease while on chemotherapy, and three patients had partial/no response. Five patients were salvaged with second-line treatment and are alive and well when last seen. Five died, and 15 patients were lost for follow up. Most relapses occurred in the patients who completed treatment (18). The most common site of relapse is primary site 17(68%), lung and local 7(28%).).